HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High affinity binding of epibatidine to serotonin type 3 receptors.

Abstract
Epibatidine and mecamylamine are ligands used widely in the study of nicotinic acetylcholine receptors (nAChRs) in the central and peripheral nervous systems. In the present study, we find that nicotine blocks only 75% of (125)I-epibatidine binding to rat brain membranes, whereas ligands specific for serotonin type 3 receptors (5-HT(3)Rs) block the remaining 25%. (125)I-Epibatidine binds with a high affinity to native 5-HT(3)Rs of N1E-115 cells and to receptors composed of only 5-HT(3A) subunits expressed in HEK cells. In these cells, serotonin, the 5-HT(3)R-specific antagonist MDL72222, and the 5-HT(3)R agonist chlorophenylbiguanide readily competed with (125)I-epibatidine binding to 5-HT(3)Rs. Nicotine was a poor competitor for (125)I-epibatidine binding to 5-HT(3)Rs. However, the noncompetitive nAChR antagonist mecamylamine acted as a potent competitive inhibitor of (125)I-epibatidine binding to 5-HT(3)Rs. Epibatidine inhibited serotonin-induced currents mediated by endogenous 5-HT(3)Rs in neuroblastoma cell lines and 5-HT(3A)Rs expressed in HEK cells in a competitive manner. Our results demonstrate that 5-HT(3)Rs are previously uncharacterized high affinity epibatidine binding sites in the brain and indicate that epibatidine and mecamylamine act as 5-HT(3)R antagonists. Previous studies that depended on epibatidine and mecamylamine as nAChR-specific ligands, in particular studies of analgesic properties of epibatidine, may need to be reinterpreted with respect to the potential role of 5-HT(3)Rs.
AuthorsRenaldo C Drisdel, Douglas Sharp, Tricia Henderson, Tim G Hales, William N Green
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 283 Issue 15 Pg. 9659-65 (Apr 11 2008) ISSN: 0021-9258 [Print] United States
PMID17702741 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Bridged Bicyclo Compounds, Heterocyclic
  • Nicotinic Agonists
  • Nicotinic Antagonists
  • Pyridines
  • Receptors, Nicotinic
  • Receptors, Serotonin, 5-HT3
  • Serotonin 5-HT3 Receptor Antagonists
  • Mecamylamine
  • Nicotine
  • epibatidine
Topics
  • Animals
  • Brain (metabolism)
  • Brain Chemistry (drug effects)
  • Bridged Bicyclo Compounds, Heterocyclic (pharmacology)
  • Cell Line, Tumor
  • Humans
  • Mecamylamine (pharmacology)
  • Mice
  • Nicotine (metabolism, pharmacology)
  • Nicotinic Agonists (pharmacology)
  • Nicotinic Antagonists (pharmacology)
  • Protein Binding
  • Pyridines (pharmacology)
  • Rats
  • Receptors, Nicotinic (genetics, metabolism)
  • Receptors, Serotonin, 5-HT3 (genetics, metabolism)
  • Serotonin 5-HT3 Receptor Antagonists

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: